"Additional research is underway to determine Brilacidin's potential effect on IL-17, a central driver of most inflammatory diseases, including many skin diseases."
http://www.ipharminc.com/new-blog/2017/6/1/br...17-pathway
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links